EXAMS · SÃO PAULO
Anti-Scl-70 test: cost, procedure and what the result means
A blood draw that helps the doctor investigate scleroderma when the skin and fingers show signs.

Understand the exam
Anti-Scl-70 is an antibody directed against a protein in cell nuclei called topoisomerase I. That is why it is also called anti-topoisomerase I.
Systemic sclerosis is an immune disease that causes hardening (fibrosis) of the skin and internal organs and affects blood vessels. A positive anti-Scl-70 is associated with a higher risk of the form in which skin hardens over larger areas of the body (diffuse form) and of disease in the lung tissue (interstitial lung disease).
A negative result does not rule out the disease: even when anti-Scl-70 is combined with other classic systemic sclerosis antibodies, some people with the disease have none of them. The result is therefore always assessed together with the consultation and other tests.
How it is done
The test involves drawing blood from a vein in the arm with a thin needle. A small amount of blood goes into a tube, which is sent for analysis.
The result goes to the doctor who ordered the test, who explains what it means together with your history and physical examination.
When it is recommended
- Raynaud’s phenomenon, when the doctor is investigating systemic sclerosis
- Hardened or thicker skin on the fingers
- Positive antinuclear antibody (ANA) test in someone with Raynaud’s phenomenon
- Recent diagnosis of systemic sclerosis, to identify the disease antibodies
Does the exam hurt?
The team explains each step of collection before starting.
After the exam
Cost and health plans
| Exam | Self-pay | Duration | Health plans |
|---|---|---|---|
| Anti-SCL 70 | From R$ 138.00 (≈ US$ 25, estimated) | Confirm with the team | Ask the team about coverage |
The team confirms the requested option, coverage, and conditions before booking.
Book an examFrequently asked questions
What does a positive anti-Scl-70 mean?
A positive result is one of the items doctors use to classify systemic sclerosis, alongside signs such as thicker skin on the fingers and Raynaud’s phenomenon. Diagnosis depends on the doctor’s evaluation and other tests.
Does a negative anti-Scl-70 rule out scleroderma?
No. Even when anti-Scl-70 is combined with other classic scleroderma antibodies, some people with the disease have none of them. The doctor interprets the findings together.
What is the difference between anti-Scl-70 and ANA?
ANA (antinuclear antibody) is a screening test that looks for antibodies against cell nuclei. Anti-Scl-70 looks for a specific antibody, anti-topoisomerase I, linked to systemic sclerosis.
Do I need to fast for the test?
The team explains preparation and visit duration when you schedule.
How long until the results are ready?
The team explains the turnaround time when assisting you.
Does my health plan cover the anti-Scl-70 test?
Check the table on this page for plans with coverage on record. If your health plan is not listed, the team will confirm coverage for you.
How much does the anti-Scl-70 test cost?
The self-pay price of the test is in the pricing table on this page.
Related exams
Where we see patients
References
- Cavazzana I, et al. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers. Clin Rev Allergy Immunol. 2023.
- Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017.
- Volkmann ER, Andréasson K, Smith V. Systemic sclerosis. Lancet. 2023.
- van den Hoogen F, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013.
- MedlinePlus. Autoantibody Testing. National Library of Medicine.
This content is informational and does not replace a consultation.
Updated on